Your browser doesn't support javascript.
loading
The Glutaminase Inhibitor CB-839 (Telaglenastat) Enhances the Antimelanoma Activity of T-Cell-Mediated Immunotherapies.
Varghese, Sruthy; Pramanik, Snigdha; Williams, Leila J; Hodges, Hannah R; Hudgens, Courtney W; Fischer, Grant M; Luo, Catherine K; Knighton, Barbara; Tan, Lin; Lorenzi, Philip L; Mackinnon, Andrew L; McQuade, Jennifer L; Hailemichael, Yared; Roszik, Jason; Peng, Weiyi; Vashisht Gopal, Y N.
Afiliação
  • Varghese S; Department of Melanoma Medical Oncology, University of Texas M.D. Anderson Cancer Center, Houston, TX.
  • Pramanik S; Department of Translational Molecular Pathology, University of Texas M.D. Anderson Cancer Center, Houston, TX.
  • Williams LJ; Department of Melanoma Medical Oncology, University of Texas M.D. Anderson Cancer Center, Houston, TX.
  • Hodges HR; Department of Melanoma Medical Oncology, University of Texas M.D. Anderson Cancer Center, Houston, TX.
  • Hudgens CW; Department of Translational Molecular Pathology, University of Texas M.D. Anderson Cancer Center, Houston, TX.
  • Fischer GM; Department of Chemical Engineering, University of Texas, Austin, TX.
  • Luo CK; Department of Translational Molecular Pathology, University of Texas M.D. Anderson Cancer Center, Houston, TX.
  • Knighton B; Department of Melanoma Medical Oncology, University of Texas M.D. Anderson Cancer Center, Houston, TX.
  • Tan L; Department of Translational Molecular Pathology, University of Texas M.D. Anderson Cancer Center, Houston, TX.
  • Lorenzi PL; Department of Cellular and Molecular Biology, John Hopkins University, Baltimore, MD.
  • Mackinnon AL; Department of Melanoma Medical Oncology, University of Texas M.D. Anderson Cancer Center, Houston, TX.
  • McQuade JL; Department of Bioinformatics and Computational Biology, University of Texas M.D. Anderson Cancer Center, Houston, TX.
  • Hailemichael Y; Department of Bioinformatics and Computational Biology, University of Texas M.D. Anderson Cancer Center, Houston, TX.
  • Roszik J; Calithera Biosciences, San Francisco, CA.
  • Peng W; Department of Melanoma Medical Oncology, University of Texas M.D. Anderson Cancer Center, Houston, TX.
  • Vashisht Gopal YN; Department of Melanoma Medical Oncology, University of Texas M.D. Anderson Cancer Center, Houston, TX.
Mol Cancer Ther ; 20(3): 500-511, 2021 03.
Article em En | MEDLINE | ID: mdl-33361272
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Linfócitos T / Inibidores de Checkpoint Imunológico / Glutaminase / Melanoma Limite: Animals / Humans Idioma: En Revista: Mol Cancer Ther Assunto da revista: ANTINEOPLASICOS Ano de publicação: 2021 Tipo de documento: Article País de publicação: Estados Unidos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Linfócitos T / Inibidores de Checkpoint Imunológico / Glutaminase / Melanoma Limite: Animals / Humans Idioma: En Revista: Mol Cancer Ther Assunto da revista: ANTINEOPLASICOS Ano de publicação: 2021 Tipo de documento: Article País de publicação: Estados Unidos